Inlet Private Wealth, LLC Charles River Laboratories International, Inc. Transaction History

Inlet Private Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$351.38 - $448.68 $210,828 - $269,208	-600 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$294.17 - $371.65 $176,502 - $222,990	600 New	600 $222,000
Q1 2020 Apr 28, 2020	SELL	$98.9 - $178.34 $148,350 - $267,510	-1,500 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$126.05 - $152.76 $189,075 - $229,140	1,500 New	1,500 $229,000
Q3 2019 Oct 17, 2019	SELL	$125.07 - $143.67 $187,605 - $215,504	-1,500 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$104.82 - $146.73 $157,230 - $220,094	1,500 New	1,500 $218,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Inlet Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Inlet Private Wealth, LLC with notifications on news.